↓ Skip to main content
What is this page? Embed badge

A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Overview of attention for article published in Cancers, August 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
8 news outlets
blogs
1 blog
twitter
2 X users
patent
2 patents

Readers on

mendeley
36 Mendeley
So far, Altmetric has seen 8 news stories from 8 outlets.
This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 4 additional news stories.